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Characterization of lysine methylation has proven
challenging despite its importance in biological pro-
cesses such as gene transcription, protein turnover,
and cytoskeletal organization. In contrast to other
key posttranslational modifications, current prote-
omics techniques have thus far shown limited suc-
cess at characterizing methyl-lysine residues across
the cellular landscape. To complement current bio-
chemical characterization methods, we developed
a multistate computational protein design procedure
to probe the substrate specificity of the protein lysine
methyltransferase SMYD2. Modeling of substrate-
bound SMYD2 identified residues important for sub-
strate recognition and predicted amino acids neces-
sary for methylation. Peptide- and protein- based
substrate libraries confirmed that SMYD2 activity is
dictated by the motif [LFM]1-K*-[AFYMSHRK]+1-
[LYK]+2 around the target lysine K*. Comprehensive
motif-based searches and mutational analysis
further established four additional substrates of
SMYD2. Our methodology paves the way to system-
atically predict and validate posttranslational modifi-
cation sites while simultaneously pairing them with
their associated enzymes.
INTRODUCTION
Posttranslational modification (PTM) of proteins adds a layer of
complexity to the proteome that is critical to biological regula-
tion. Although proteomic studies have enabled the comprehen-
sive study of PTMs such as phosphorylation and acetylation,
the characterization of many other types of PTMs remains a sig-
nificant challenge (Choudhary et al., 2009; Ptacek et al., 2005).
Among these, lysine methylation—the transfer by protein lysine
methyltransferases (PKMTs) of one, two, or three methyl groups
to the ε-amine of a lysine side chain (Schubert et al., 2003)—is a206 Structure 23, 206–215, January 6, 2015 ª2015 Elsevier Ltd All rigprevalent PTM associated with critical cellular processes
including cell cycle progression, chromosome segregation,
and pathogen infection (Lanouette et al., 2014). The relatively
low abundance and chemically inert nature of lysine methylation
hinder its detection by current proteomics methods. Moreover,
the expensive and technically challenging protocols currently
used to study lysine methylation limit the high-throughput
biochemical characterization of PKMT substrates (Kudithipudi
et al., 2012, 2014; Rathert et al., 2008).
SMYD2 is a PKMT that plays critical roles in muscle develop-
ment and myofibril formation (Blais et al., 2005; Donlin et al.,
2012; Voelkel et al., 2013) as well as proper endodermal devel-
opment during embryonic stem cell differentiation (Sese´ et al.,
2013). It is misregulated in esophageal squamous cell carci-
nomas (Komatsu et al., 2009), bladder tumors (Cho et al.,
2012), leukemia stem cells (Sakamoto et al., 2014; Zuber et al.,
2011), and doxorubicin-resistant breast cancer (Barros Filho
et al., 2010). The oncogenic phenotypes of SMYD2 depend on
its methyltransferase activity (Komatsu et al., 2009; Sakamoto
et al., 2014), which has also been shown to regulate gene tran-
scription (methylation of histone H3, Abu-Farha et al., 2008;
and estrogen receptor a (ERa) Zhang et al., 2013), cell cycle pro-
gression (methylation of Retinoblastoma protein; Cho et al.,
2012; Saddic et al., 2010), apoptosis (methylation of p53; Huang
et al., 2006) and oxidative stress (methylation of poly [ADP-
ribose] polymerase 1; Piao et al., 2014). The substrates currently
known for SMYD2 are most likely only a subset of its full range of
methylation targets.
The crystal structure of the SMYD2-p53 complex shows that
substrate binding occurs in a narrow cleft between the catalytic
SET domain and a C-terminal tetratricopeptide repeat domain
(Ferguson et al., 2011; Sirinupong et al., 2010, 2011). Because
SMYD2 substrates display little sequence or structural similarity,
the mechanism by which this interface directs substrate speci-
ficity is currently unknown. A better understanding of the
structural determinants of SMYD2 specificity would thereby
allow for the identification of additional substrates, providing in-
formation on its underlying biological functions and disease
associations.
We present here a computational protein design (CPD)
approach to define a substrate recognition motif for SMYD2.hts reserved
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Computational Design Predicts SMYD2 SubstratesThis approach is based onmultistate design (MSD), an emerging
methodology in CPD that predicts stable protein sequences in
the context of multiple backbones instead of a single fixed back-
bone template (Davey and Chica, 2012). We also appraised
SMYD2 specificity using methyltransferase assays on both pep-
tide and full-length protein substrates. The recognition motifs
derived using both computational and experimental techniques
were in remarkable agreement and established that SMYD2 rec-
ognizes the [LFM]1-K*-[AFYMSHRK]+1-[LYK]+2 sequence. In
combination with bioinformatics analyses andmethyltransferase
assays, we found four previously unknown substrates of
SMYD2: SIN3B, SIX1, SIX2, and DHX15, demonstrating the util-
ity of MSD as a discovery tool for the study of PTM enzymes.
RESULTS AND DISCUSSION
Prediction of SMYD2 Substrate Recognition Motif
by Multistate Design
Several CPD protocols have been developed to design the
specificity and stability of protein-protein interactions (Karanico-
las and Kuhlman, 2009; Mandell and Kortemme, 2009). These
protocols are typically based on the single-state design (SSD)
approach whereby protein sequences are optimized in the
context of a single protein complex structure (Alvizo et al.,
2012; Grigoryan and Keating, 2006; Sammond et al., 2007). In
this approach, discrete amino acid side chain rotamers are first
threaded on the fixed polypeptide chain of each binding pair
protein, followed by rotamer refinement to improve their pack-
ing interactions at the protein-protein interface. A list of ranked
sequences is then returned based on their score value following
sequence optimization. Additional procedures including protein
docking (Huang et al., 2007b; Jha et al., 2010) and flexible back-
bone design (Smith and Kortemme, 2008) can also be incorpo-
rated in this process to improve predictions. Recently, MSD, a
CPD methodology that uses conformational ensembles as in-
puts instead of a single backbone template, was developed
as an alternate approach for the design of protein-protein inter-
faces (Humphris and Kortemme, 2008). MSD improves the pre-
diction of stable and functional protein sequences (Allen et al.,
2010; Babor et al., 2011; Davey and Chica, 2014) through
improved packing interactions resulting from small variations
in backbone geometry. Although MSD has been used to reca-
pitulate known binding interactions (Smith and Kortemme,
2010) and to engineer new ones (Grigoryan et al., 2009; Kapp
et al., 2012), it has not yet been applied toward the prediction
and discovery of previously unknown substrates of PTM
enzymes.
In this study, we developed a computational approach based
on MSD to predict the substrate recognition space of SMYD2.
We first generated in silico an ensemble of 180 different back-
bone configurations of SMYD2 bound to a p53-derived peptide
(Protein Data Bank [PDB] ID 3S7F, Figure 1A) to be used as
our MSD input models. This ensemble was prepared using the
coordinate perturbation and energy minimization (PertMin) algo-
rithm that we previously developed (Davey and Chica, 2014).
PertMin involves the random perturbation of atomic coordinates
followed by an energy minimization procedure that forces the
calculation to adopt divergent descent trajectories resulting
from the small coordinate changes to the input structure. Thus,Structure 23, 20PertMin results in an ensemble of similar protein structures found
at alternate local minima that simulate conformational flexibility.
As shown in Figure 1B, the resulting p53 peptide conformations
in the PertMin ensemble adopt the same relative orientation in
the SMYD2 binding cleft and occupy a tight conformational
space. These conformations also preserve the interactions that
the p53 side chains (Figure 1C) and backbone (Figure 1D)
make with the SMYD2 binding cleft. Inspection of the ensemble
also shows that structural variation of the p53 peptide backbone
is lower at positions 1, +1, and +2 relative to the K370 methyl-
ation site, suggesting that they dictate recognition through stron-
ger interactions. We thus retained these positions for further
design calculations.
Next, we used MSD to optimize each amino acid substitution
with the exception of proline at positions 1, +1, and +2 of the
p53 peptide in the context of the ensemble, evaluating a total
of 57 substitutions. To predict the tolerated amino acid substitu-
tions at each designed position, we calculated the fitness of each
substitution by computing the Boltzmann weighted average of
its interaction energy with the SMYD2-p53 complex (see Exper-
imental Procedures) in the context of each member of the
ensemble. As a result, the fitness value does not directly reflect
binding affinity since the change in free energy (bound versus un-
bound) for each peptide is not computed. Instead, the fitness
value reports on the ability of each substitution to stabilize the
SMYD2-p53 complex while preserving the binding mode repre-
sented in the ensemble.
As shown in Table 1, all substitutions with the exception of W
and Y at position +2 result in negative and thus favorable fitness
values, suggesting that they potentially stabilize the complex in
the binding mode represented by the ensemble. To determine
which residues to include in the predicted recognition motif,
we clustered all substitutions at each designed position accord-
ing to the similarity of their fitness values using the k-means
cluster analysis algorithm (Kanungo et al., 2002). The k-means
algorithm is an iterative method of clustering numerical values
by partitioning them according to their Euclidian distance from
each cluster centroid, which in this case is the average fitness
value of each substitution belonging to the cluster. We parti-
tioned each substitution with a negative fitness value into one
of three clusters (Table 2 and Experimental Procedures), with
cluster k1 containing the most favorable substitutions. A substi-
tution was predicted to be part of the SMYD2 substrate recog-
nition motif if it is grouped in a cluster of equal or better fitness
to the cluster containing the wild-type p53 amino acid (L1/K0/
S+1/K+2) at that position. Thus, residues found in the k1 cluster
of positions +1 and +2 as well as those from the k1 and k2 clus-
ters of position 1 were included in the recognition motif
[LFMK]1-K*-[AFMSKC]+1-[KLIM]+2 (where K* is the methylated
lysine) predicted by MSD. Interestingly, our k-means analysis
showed that position +1 is more tolerant to substitution as
more amino acids are included in the top cluster than that of po-
sitions1 and +2. This result is in agreement with available crys-
tal structures of SMYD2 in complex with ERa and p53, which
show that the side chain of the residue at position +1 is oriented
outward of the binding cleft (Ferguson et al., 2011; Jiang et al.,
2014), likely allowing for a broader range of substitutions by
enabling a higher number of rotamers to be scored favorably
at this position.6–215, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 207
Figure 1. Peptide Flexibility in SMYD2 Sub-
strate Binding Cleft
(A) Structure of SMYD2 (PDB ID 3S7F) with bound
p53 peptide (stick model). SMYD2 residues
forming the substrate binding cleft are highlighted
in purple.
(B) p53 substrate peptide backbones included in
the 180-member PertMin ensemble. Amino acid
positions relative to the methylated K370 residue
are indicated. Crystallographic coordinates of the
p53 peptide are shown in gray.
(C) Binding interactions between side chains of the
p53 peptide and SMYD2 residues forming the
binding cleft (purple) and the methyl transfer
channel (gray). Two hydrophobic pockets (purple)
stabilize the side chains of p53 residues at posi-
tions 1 and +2 whereas no interactions stabilize
the side chain of the residue at position +1.
(D) Binding interactions of the p53 peptide back-
bone by SMYD2 residues forming the binding cleft
(purple) and the methyl transfer channel (gray).
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Computational Design Predicts SMYD2 SubstratesHigh-Throughput Methyltransferase Assays Reveal
SMYD2 Specificity
To validate the SMYD2 recognition motif predicted by MSD, we
designed a SPOT peptide array (Hilpert et al., 2007; Winkler and
Campbell, 2008) based on the p53 sequence surrounding the
SMYD2 target lysine K370 (SSHLK370SKKGQ); each position of
the peptide was substituted for every possible amino acid sub-
stitution. Three identical arrayswere incubatedwith recombinant
SMYD2 and 3H-labeled AdoMet under conditions which repro-208 Structure 23, 206–215, January 6, 2015 ª2015 Elsevier Ltd All rights reservedduce SMYD2 specificity (Figure S1 avail-
able online) and peptide methylation was
quantified by phosphorimaging (Fig-
ure 2A). The normalized averaged inten-
sities indicate that positions1 to +2 sur-
rounding K370 are the main determinants
of SMYD2 activity (Figure 2B). In contrast,
positions4 to2 and +3 to +5 show the
highest tolerance to substitutions, vali-
dating our choice of positions designed
by MSD.
To precisely define the SMYD2 sub-
strate recognition motif, we calculated
the relative methylation factor for each
amino acid as the ratio of methylation
for a given substitution relative to the dif-
ference of its methylation and the
average methylation of all other substitu-
tions at this position. This relative
methylation factor thus reflects the pref-
erence of SMYD2 for a specific substitu-
tion at one position relative to all other
substitutions. Consistent with MSD pre-
dictions, we observed that SMYD2 ex-
hibits a strong preference for L, F, and
M residues at position 1 (Figure 2C).
In contrast, position +1 has a broad
tolerance with eight of 20 substitutionsallowing preferential methylation. This result is consistent with
the solvent-exposed orientation of side chains at position +1
found in the PertMin ensemble. Similar to residues found at po-
sition 1, +2 residues remain in a deep pocket within the
SMYD2 peptide binding cleft (Figure 1C). Accordingly,
SMYD2 shows narrow specificity for peptides containing K, L,
or Y substitutions at this position. Analysis of the relative
methylation factors demonstrates that SMYD2 preferentially
methylates the motif [LFM]1-K*-[AFYMSHRK]+1-[LYK]+2.




Fitnessb: k1 < k2 < k3
k1: F
1 k2: K M L
k3: C I H R T W V Y A E D G N Q S
k1: A C F K M S
+1 k2: E D G H L N Q R T W Y
k3: I V
k1: I K M L
+2 k2: A C H V
k3: E D G F N Q S R T
aThe wild-type p53 residue at each position is underlined and in bold.
bClusters ranked higher have more negative fitness values (kcal/mol).
Table 1. Fitness Values Calculated by MSD for Amino Acid
Substitutions Found at Three Positions on the p53 Peptide
Substitution
Fitnessa (kcal/mol) at Position
1 +1 +2
A 62.39 84.32 65.32
C 72.62 86.53 75.70
D 64.14 64.49 52.54
E 69.06 72.43 58.71
F 92.88 79.09 61.56
G 59.27 73.00 51.82
H 79.14 63.85 72.19
I 79.54 16.60 80.28
K 91.28 86.08 84.64
L 88.03 75.05 82.41
M 90.02 86.25 82.63
N 65.45 65.05 52.95
Q 68.71 75.06 60.73
R 71.98 75.82 36.08
S 65.18 81.27 55.10
T 75.20 73.80 61.75
V 74.46 51.40 75.58
W 78.52 69.00 62.68
Y 77.50 76.63 140.53
aFitness values are the Boltzmann weighted average of individual scores
in the context of each member of the ensemble.
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Computational Design Predicts SMYD2 SubstratesAccuracy of In Silico Predictions
The recognition motif predicted using MSD is in excellent agree-
ment with results from our high-throughput methyltransferase
assays (Figure 2D). Our in silico model accurately predicted
that SMYD2 recognition is predominantly determined by amino
acid identity at positions1, +1 and +2 of the substrate peptide.
The narrow specificity of SMYD2 for substitutions at position 1
observed in SPOT arrays is correctly identified byMSD, because
position1 includes only one false-positive substitution (K) in the
clusters considered (Table 2, k1 and k2 clusters). SMYD2 meth-
yltransferase activity shows a strong bias toward long side chain
hydrophobic residues L, F, and M at position1, possibly due to
the stabilization of these side chains in a hydrophobic pocket
(Figure 1C) (Ferguson et al., 2011). MSD also correctly predicted
a more relaxed specificity at position +1 (Table 2), with cluster k1
recapitulating five of the eight substitutions observed to be favor-
able in vitro (Figure 2D). Interestingly, Y at position +2 is one of
the most unfavorable substitutions predicted by MSD whereas
it is included in the recognitionmotif derived from the SPOT array
experiments. This discrepancy may be due to the absence in our
PertMin ensemble of an adequate p53 peptide backbone
conformation required to favorably score this substitution. Avail-
able crystal structures of SMYD2 complexes (Ferguson et al.,
2011; Jiang et al., 2014) show this residue embedded in a
deep hydrophobic pocket (Figure 1C) that accommodates resi-
dues with long side chains, an observation consistent with
the motif defined by MSD and the SPOT arrays. While our meth-
yltransferase assays directly assessed the processivity of
SMYD2 toward peptide substrates, MSD assessed the stabiliza-Structure 23, 20tion potential of its binding cleft. The agreement of both methods
suggests that association may be the main driver of SMYD2
specificity.
While there is remarkable agreement between recognitionmo-
tifs predicted by both MSD and peptide arrays, there are four
false-negative (H/R/Y and Y at positions +1 and +2, respectively)
and four false-positive (K, C, and I/M at positions1, +1, and +2,
respectively) substitutions predicted by MSD. To evaluate
whether an alternate binning method could have resulted in
fewer false-positive and false-negative substitutions, we used
the fitness value of the wild-type at each designed position (Ta-
ble 1) as a cutoff to include or exclude substitutions from the
recognition motif predicted by MSD. As shown in Figure S2,
use of the wild-type fitness value cutoff results in identical (posi-
tion 1) or lower (positions +1 and +2) true-positive ratios. In
contrast, clustering substitutions with the k-means algorithm al-
lowed an additional two substitutions to be correctly accepted in
the recognition motif (one at position +1 and one at position +2)
while incorrectly including only one false-positive substitution at
position +2, demonstrating the benefit of using k-means clus-
tering over binning with the wild-type fitness value.
To assess whether MSD provided improved prediction accu-
racy compared to SSD, we performed SSD on a single fixed
backbone using identical parameters as those used for MSD
except that single-state scores were used to rank sequences
instead of the Boltzmann weighted average fitness value. Fig-
ure 3A shows a comparison of the SSD scores and MSD fitness
values computed for all substitutions except for W and Y at
position +2, which were omitted because both their MSD fitness
values and SSD scores are > 0 kcal/mol. In all cases, regardless
of substitution or position, MSD fitness values were more nega-
tive than SSD scores, indicating that substitutions are scored
more favorably in the context of a backbone ensemble rather
than a single structure. In the case of ten substitutions (F/H/I/L/
M/V/W/Y and F/I at positions +1 and +2, respectively), SSD
scores fell above our accepted threshold of 0 kcal/mol. The
high SSD scores for these ten substitutions indicate unfavorable
interactions likely resulting from steric clashes. This result is
consistent with a known artifact of SSD arising from the com-
bined use of a fixed protein backbone template with rigid ro-
tamers, which can lead to the rejection of favorable amino acid6–215, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 209
Figure 2. Substrate Recognition Motif of
SMYD2
(A) Methylation of a SPOT peptide array containing
200 peptides based on the p53 template
sequence in which each position was systemati-
cally substituted for every amino acid. Labeling by
tritiatedmethyl was detected by phosphorimaging
after incubation with recombinant SMYD2 and
3H-AdoMet.
(B) Heat map representation of average methyl-
ation intensities measured by phosphorimaging.
(C) Analysis of the relative methylation factor for
every amino acid at each position of the SPOT
arrays (n = 3).
(D) Comparison of SMYD2 substrate recognition
motifs determined by methyltransferase high-
throughput assays (SPOT) and MSD calculations.
Green, blue, and black represent hydrophobic,
charged, and polar residues, respectively. The
methylated K370 residue is indicated with an
asterisk.
Structure
Computational Design Predicts SMYD2 Substratessequences that would have been accepted on a slightly different
backbone geometry or with a slightly different rotamer configu-
ration (Choi et al., 2010).
To further compare the prediction accuracy obtained by SSD
and MSD, we calculated the true-positive (fraction of true-posi-
tive substitutions out of the positives) and false-positive (fraction
of false-positive substitutions out of the negatives) ratios forFigure 3. Comparison of SSD and MSD Predictions
(A) MSD fitness values are plotted as a function of SSD scores for a total 55 substitutions found on the p53
methylated lysine. The 45 substitutions that resulted in negative (favorable) fitness and score values are show
negative (favorable) MSD fitness values and positive (unfavorable) SSD scores are shown as triangles. To
arbitrary positive SSD scores on the plot.
(B) ROC curve for all substitutions at all positions obtained using SSD scores.
(C) ROC curve for all substitutions at all positions obtained using MSD fitness values. The diagonal line repr
210 Structure 23, 206–215, January 6, 2015 ª2015 Elsevier Ltd All rights reservedevery possible cutoff value at 1 kcal/mol
increments in the range of score/fitness
values obtained for all substitutions, and
plotted them to generate receiver oper-
ating characteristic (ROC) curves (Fig-
ure 3). ROC curves show that a significant
improvement in prediction accuracy is
obtained by using MSD as evidenced by
the larger area under the curve that indi-cates a higher probability of ranking a randomly chosen positive
higher than a randomly chosen negative. The lower prediction
accuracy of SSD results from its poor scoring of substitutions
to position +1, which results in four additional false-negative
substitutions (F, H, M, and Y). This incorrect rejection of true-
positive substitutions decreases the true-positive ratio to 0.5,
a value that cannot be improved over a broad range of cutoffspeptide at positions 1, +1, and +2 relative to the
n as circles. The ten substitutions that resulted in
simplify, these ten sequences are given identical
esents random binning.
Figure 4. Prediction of SMYD2 Substrates among Its Interactome
(A) Ninety-five proteins reported to interact with SMYD2 include the [LFM]1-K*-[AFYMSHRK]+1-[LYK]+2motif determined fromSPOT arrays while 137 include the
[LFMK]1-K*-[AFMSKC]+1-[KLIM]+2 predicted by MSD. Seventy-three of these proteins contain sequences common to both recognition motifs.
(B) Analysis of gene ontology terms associated to the 95 putative SMYD2 targets containing the [LFM]1-K*-[AFYMSHRK]+1-[LYK]+2 motif (green). Among the 22
hits corresponding to terms related to SMYD2 functions, localization and phenotypes, 11 include a lysine conserved in humans (Homo sapiens), mice (Mus
musculus), frogs (Xenopus laevis), and fish (Danio rerio) (conservation of all sites across two to three species or across all four species is indicated in light or dark
blue, respectively).
Structure
Computational Design Predicts SMYD2 Substratesthat instead only increase the false-positive ratio. In contrast,
predictions made by MSD result in a large increase to the true-
positive ratio that is accompanied by a small increase in the
false-positive ratio. It is likely that similar improvements to pre-
diction accuracy could also be achieved through the use of alter-
nate CPD methodologies that incorporate backbone flexibility
during calculation (Murphy et al., 2012; Smith and Kortemme,
2008). Although predictions could not be improved by using
SSD or an alternate binning method, MSD combined with
k-means cluster analysis correctly binned substitutions as either
being part or not of the recognition motif elucidated by SPOT
array analysis with an overall accuracy of 86% (49/57), demon-
strating the utility of this approach to the prediction of substrate
recognition motifs for PKMTs.
SMYD2 Substrates Include the [LFM]–1-K*-
[AFYMSHRK]+1-[LYK]+2 Motif
We next sought to determine whether the recognition motifs
could be used to discover additional SMYD2 methylation tar-
gets. We probed a data set of all reported genetic and physical
SMYD2 protein interactors (Abu-Farha et al., 2008, 2011; Brown
et al., 2006; Cho et al., 2012; Donlin et al., 2012; Huang et al.,Structure 23, 202006, 2007a; Saddic et al., 2010; Voelkel et al., 2013) using the
ScanProsite motif search tool (de Castro et al., 2006). Among
our data set, 95 SMYD2 interactors include the peptide array
motif [LFM]1-K*-[AFYMSHRK]+1-[LYK]+2 and 137 include the
MSD motif [LFMK]1-K*-[AFMSKC]+1-[KLIM]+2 (Table S1). As
expected from their similarity, the recognition motif predicted
by MSD identified a majority (77%) of the SMYD2 putative
methylation targets identified using the motif determined by
SPOT array (Figure 4A).
To refine our list of possible substrates, we cross-referenced
the gene ontology (GO) terms of the 95 SMYD2 interactors
with expression patterns and biological activities of this PKMT.
Using the DAVID Bioinformatics Resources Functional Annota-
tion Tool (Huang et al., 2009), we selected 22 proteins corre-
sponding best to reported or proposed SMYD2 biological func-
tions (Figures 4B and S3). We also assessed the conservation of
the putative site in mammals, birds, and fish. Of the selected pu-
tative targets, ten proteins were expressed as FLAG-tagged
constructs and incubated with recombinant SMYD2 and
3H-labeled AdoMet. Autoradiography confirmed that SMYD2
methylates the transcription factors SIX1 (Heanue et al., 1999)
and SIX2 (Boucher et al., 2000), the transcriptional corepressor6–215, January 6, 2015 ª2015 Elsevier Ltd All rights reserved 211
Figure 5. SIX1, SIX2, SIN3B, and DHX15 Are SMYD2 Substrates
(A) Autoradiography of FLAG-tagged proteins incubated with recombinant
SMYD2 and 3H-AdoMet transcription factor E2F1, mitogen-activated protein
kinase 11 (MAPK11), RNA polymerase II subunit A C-terminal domain phos-
phatase (FCP1), Staufen 1 (STAU1), DEAD box RNA helicase 5 (DDX5), SIN3B,
DEAH box RNA helicase 15 (DHX15), and Sine Oculis Homeobox homolog 1,
2, and 4 (SIX1, SIX2, SIX4). Upper panels show the proteins stained by Coo-
massie following SDS-PAGE and the lower panels show the resulting auto-
radiography. Transcription factors SIX1 and SIX2, corepressor SIN3B, and
RNA helicase DHX15 are all methylated by SMYD2.
(B) Autoradiography of wild-type and mutant SIX1 and SIN3B incubated with
recombinant SMYD2 and 3H-AdoMet. Upper and lower panels are as
described in (A).
(C) Alignment of amino acid sequences surrounding all known SMYD2
methylation sites (black). Residues included in the SMYD2 recognition
Structure
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212 Structure 23, 206–215, January 6, 2015 ª2015 Elsevier Ltd All rigSIN3B (Ayer et al., 1995), and the RNA helicase DHX15 (Wen
et al., 2008) (Figure 5A). Furthermore, SMYD2 cannot methylate
single-point mutants of SIN3B and SIX1 in which the predicted
target lysine is substituted for arginine, confirming that our motif
correctly predicts methylation sites on proteins (Figure 5B).
Notably, SMYD2 did not methylate six of the proteins identified
by GO analysis. It is likely that the putative target lysine of these
proteins is either not solvent exposed or engaged in intramolec-
ular interactions with other residues of the motif, preventing
methylation by SMYD2. SMYD2 substrates identified in this
study contain a recognition sequence (Figure 5C) that is included
in both the SPOT array andMSDmotifs, demonstrating the utility
of MSD for the discovery of uncharacterized lysine methylation
targets for a PKMT.
The sequence surrounding the methylation site (K266) on the
ERa is included in our motif (Zhang et al., 2013). Accordingly,
corresponding residues on this substrate peptide bind to
SMYD2 in a conformation nearly identical to that seen in the
SMYD2-p53 complex (Jiang et al., 2014). In contrast, our motif
would not have predicted the methylation of HSP90 and pRb
by SMYD2 (Figure 5C). Most likely, the recognition sites of these
protein substrates adopt alternate peptide conformations not
probed by our PertMin ensemble or consist of divergent se-
quences not covered in our SPOT arrays. These observations
suggest that substrates included in our motif bind in a conforma-
tion resembling the structure of p53 when bound to SMYD2 and
that SMYD2 also recognizes substrates (HSP90 and Rb) adopt-
ing an alternative binding mode. These findings are consistent
with our previous study showing that SMYD2 is controlled by a
‘‘specificity-switch’’ enabling the methylation of distinct pools
of substrates (Abu-Farha et al., 2011).
Conclusions
We showed that SMYD2 methylates the sequence motif
[LFM]1-K*-[AFYMSHRK]+1-[LYK]+2 with position 1 and +2 ex-
hibiting the highest degree of selectivity. Combining different
bioinformatics and biochemical approaches with the motifs
defined by MSD and SPOT arrays, we found additional sub-
strates for SMYD2. Interestingly, the methylation sites in SIX1,
SIX2, and SIN3B are located in the protein-protein interaction
domain (Figure 5D). In SIX1 and SIX2, the methylation site K51
is located at the surface of the SIX1 domain of both transcription
factors in a region known to interact with the EYA transcriptional
activator (Patrick et al., 2013). In SIN3B, the methylation site is
located in the interaction domain that contacts the adaptor pro-
tein SUDS3 (Alland et al., 2002). Methylation of p53, HSP90,
pRb, and ERa by SMYD2 was already shown to control the as-
sociation of their binding partners (Cho et al., 2012; Huang
et al., 2006; Jiang et al., 2014; Voelkel et al., 2013); our findings
suggest that this mechanism may be shared by numerous sub-
strates of SMYD2. These four substrates also provide promising
avenues to explore the critical role of SMYD2 in organ develop-
ment (Diehl et al., 2010; Donlin et al., 2012) and regulation of
gene expression (Abu-Farha et al., 2008; Brown et al., 2006).motif are highlighted in green and those that are not are highlighted
in red.




Computational Design Predicts SMYD2 SubstratesHigh-throughput methyltransferase assays showed that MSD
correctly characterized the substrate sequence space recog-
nized by SMYD2. In addition to biochemical characterization,
CPD techniques can thus be used to study the spectrum of
specificity of other posttranslational modifying enzymes. In
contrast with current methods, MSD provides a rapid and inex-
pensive way to probe the specificity of a posttranslational modi-
fying enzyme based on its enzyme-substrate interface. This
method combining multistate computational protein design
and k-means cluster analysis demonstrates that CPD can be
applied to the discovery of previously unknown substrates of
PTM enzymes.
EXPERIMENTAL PROCEDURES
Multistate Computational Protein Design
Atomic coordinates for the p53-bound structure of SMYD2 (Ferguson et al.,
2011) were retrieved from the PDB (ID 3S7F). Hydrogens were added using
the Protonate3D utility found in theMolecular Operating Environment software
suite (Chemical Computing Group, 2012). A 180-member PertMin ensemble
(Davey and Chica, 2014) of the SMYD2-p53 complex was generated from
the crystal structure with hydrogens added by randomly perturbing the coor-
dinates of all atoms by ±0.001 A˚ along each Cartesian coordinate axis.
Because coordinate deviation from crystal structure increases proportionately
with the number of minimization iterations, we energy minimized six sets of 30
perturbed structures using a truncated Newton minimization algorithm for 10,
25, 50, 100, 150, and 250 iterations, resulting in structures displaying a broad
range of deviations from the crystal structure. The energy minimizations were
performed using the AMBER99 force field (Wang et al., 2000) with a distance-
dependent dielectric of 80. The input structure used in SSD was prepared in a
similar fashion from the initial SMYD2-p53 structure with added hydrogens by
performing 50 iterations of conjugate gradient energy minimization.
MSD of the SMYD2-p53 complex was conducted using the fast and accu-
rate side-chain topology and energy refinement (FASTER) algorithm for
sequence optimization (Allen and Mayo, 2006, 2010). All amino acids with
the exception of proline were introduced at p53 positions 1, +1, and +2 rela-
tive to the methylated lysine. Adjacent SMYD2 residues found in the binding
cleft were allowed to sample alternate conformations during the design, but
their identities were not modified (SMYD2 residues 19, 105, 108, 135, 179,
180, 181, 182, 184, 187, 191, 193, 196, 211, 215, 217, 238, 239, 240, 258,
344, 379, and 380). A backbone-dependent Dunbrack rotamer library with ex-
pansions of ±1 SD around side chain c1 and c2 rotatable bonds was used
(Dunbrack and Cohen, 1997). The interaction energies of amino acid substitu-
tions were scored using a four-term potential energy function that includes a
van der Waals term from the Dreiding II force field where atomic radii were
scaled by 0.9 (Mayo et al., 1990), a hydrogen-bond term with a well depth of
8 kcal/mol and direction-specific variables (Dahiyat and Mayo, 1997), a
Coulomb electrostatic term with a distance-dependent dielectric of 40, and
a surface area-based solvation penalty term (Lazaridis and Karplus, 1999;
Street and Mayo, 1998). MSD was implemented using PHOENIX (Allen et al.,
2010; Chica et al., 2010; Privett et al., 2012). Substitution fitness was
computed as the Boltzmann weighted average of scores across the 180mem-
bers of the PertMin ensemble at 300 K and these fitness values were clustered
using the k-means theorem (Kanungo et al., 2002).
Protein Preparation and Assays
Recombinant SMYD2 was expressed and purified as described previously
(Abu-Farha et al., 2011). C-terminal bound peptides for high-throughput meth-
yltransferase assays were synthesized by the SPOT method on a trioxatride-
canediamine (Hilpert et al., 2007). Themethylation factor was calculated by us-
ing the formula (IiIj*)/Ij*, where Ii is the intensitymeasured for peptide i and Ij* is
the average of intensities of all the peptides for this position, excluding i. For
substrate validation assays, FLAG-tagged constructs of the putative sub-
strates were transfected in HEK293T cells. Cells were lysed 24 hr after trans-
fection in 50 mM Tris pH 7.5, 10 mM NaCl, 5 mM EDTA, and 0.4% NP-40.
FLAG-tagged proteins were immunopurified using anti-FLAG M2 magneticStructure 23, 20beads (Life Technologies). Beads were adjusted to 50% v/v in 50 mM Tris
pH 8.0 and incubated with 1.5 mCi of 3H-AdoMet for 2 hr at 30C either in
the presence or absence of recombinant SMYD2 (10 ng/ml). Proteins were
separated on a SDS-PAGE gel and methylation was demonstrated with auto-
radiography (Abu-Farha et al., 2011). Additional methods are provided in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2014.11.004.
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